Patients may become immune to botulinum toxin treatments
(HealthDay)—About 15 percent of patients treated with botulinum toxin type A (BoNT/A) for dystonia or spasticity can develop an immune response to the treatment itself, according to a study published online Nov. 21 in Neurology.
Dec 12, 2018
0
0